Okla. Stat. tit. 63, § 63-5026.1

for sickle cell disease.

A. The Oklahoma Health Care Authority shall conduct an annual

review of all medications and forms of treatment for sickle cell

disease and services for enrollees with a diagnosis of sickle cell

disease. The purpose of the annual review is to determine if the

available covered medications, treatments, and services are adequate

to meet the needs of enrollees with a diagnosis of sickle cell

disease, and whether the Authority should seek to add or recommend

additional medications, treatments, or services.

B. The review shall include, but not be limited to:

1. The extent to which healthcare transitional programs covered

under the state Medicaid program prepare, transfer, and integrate

emerging adults into the adult care setting from a pediatric

setting;

2. The extent to which emergency department providers are

adequately trained and otherwise prepared to treat and manage sickle

cell patients presenting with vaso-occlusive crises including but

not limited to the extent to which providers follow clinically

Oklahoma Statutes - Title 63. Public Health and Safety Page 1728

validated algorithms and protocols regarding such treatment and

management;

3. The extent to which sickle cell patients covered under the

state Medicaid program are entitled to receive the same standard of

care when referred or transferred to an out-of-state facility, and

the extent to which the state reimburses such patients for

reasonable interstate travel costs; and

4. Any additional areas identified by the Authority that impact

the care and treatment of individuals in this state living with

sickle cell disease or sickle cell trait.

C. When conducting the annual review required by this section,

the Authority shall solicit and consider input from the general

public, with specific emphasis on seeking input from persons or

groups with knowledge and experience in the area of sickle cell

disease treatment.

D. To the extent practicable, the Authority shall utilize the

Oklahoma State Health Information Network and Exchange created under

Section 1-133 of Title 63 of the Oklahoma Statutes to collect

information for the purpose of implementing this section.

E. On or before January 15, 2023, and on or before January 15

each year thereafter, the Authority shall submit a report to the

President Pro Tempore of the Senate and the Speaker of the House of

Representatives for distribution to the appropriate subject matter

committees that details the Authority's findings from the annual

review required by this section and any recommendations to the

Legislature based upon those findings. The Authority shall publish

the annual report required by this subsection to its website in a

manner accessible by the general public.